title: Biomarkers of cardiometabolic risk in obese/overweight children: effect of lifestyle intervention.
abstract: Obesity is a strong cardiometabolic (CM) risk factor in children. We tested potential CM risk in obese/overweight children and the effect of an intensive lifestyle intervention using newer CM markers: atherogenic index of plasma AIP [Log(TG/HDL-C)], apoB/apoAI ratio and a marker of insulin resistance HOMA-IR. The participants (194 girls, 115 boys, average age 13) were enrolled in an intensive, one-month, inpatient weight reduction program. The program consisted of individualised dietary changes and the exercise program comprised aerobic and resistance training. Anthropometrical and biochemical parameters in plasma and CM risk biomarkers - (AIP, apoB/apoAI ratio and HOMA-IR) were examined before and after the intervention. AIP and HOMA-IR significantly correlated with BMI while apoB/apoAI ratio did not. Only AIP and HOMA-IR showed systematic increases according to the level of obesity by BMI quartiles. Lifestyle intervention significantly improved anthropometrical and biochemical values and the biomarkers too. The response of lipid parameters to the intervention was considerably higher in boys than in girls. The children were stratified into three risk categories according to AIP, where 13.8 % of boys and 5.3 % of girls fell into high risk category. The monitored biomarkers may complement each other in the prognosis of CM risk. AIP was strongly related to obesity and to lipid and glycid metabolism, while the relationship of the apoB/apoAI ratio to obesity and glycid metabolism was not significant. The obese children benefited from the intensive lifestyle intervention which improved the anthropometrical and biochemical parameters and CM risk biomarkers.
authors.affiliation: Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic. dobias@biomed.cas.cz.
authors.forename: M
authors.initials: M
authors.lastname: Vrablík
authors.forename: M
authors.initials: M
authors.lastname: Dobiášová
authors.forename: L
authors.initials: L
authors.lastname: Zlatohlávek
authors.forename: Z
authors.initials: Z
authors.lastname: Urbanová
authors.forename: R
authors.initials: R
authors.lastname: Češka
mesh_terms: D000293:Adolescent; D016632:Apolipoprotein A-I / Q000032:analysis; D001055:Apolipoproteins B / Q000032:analysis; D015415:Biomarkers / Q000032:analysis*; D002648:Child; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008019:Life Style; D008297:Male; D009765:Obesity / Q000378:metabolism* / Q000534:rehabilitation; D050177:Overweight / Q000378:metabolism* / Q000534:rehabilitation; D018570:Risk Assessment / Q000379:methods*; D012727:Sex Characteristics; D016896:Treatment Outcome
chemical_list: D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D015415:Biomarkers